34 | Opioid Analgesics (Opioids)IBA
04/2024
-
09/2002 |
18 | Morphine (MS Contin)FDA LinkGeneric
09/2022
-
01/2003 |
15 | Analgesics (Analgesic Drugs)IBA
04/2024
-
11/2005 |
13 | Toll-Like Receptor 4IBA
01/2021
-
07/2008 |
11 | Naltrexone (ReVia)FDA LinkGeneric
01/2021
-
07/2008 |
10 | Dopamine (Intropin)FDA LinkGeneric
01/2023
-
05/2006 |
10 | Opioid Receptors (Opioid Receptor)IBA
04/2022
-
03/2006 |
10 | Serotonin (5 Hydroxytryptamine)IBA
01/2018
-
09/2009 |
8 | Ethanol (Ethyl Alcohol)IBA
01/2021
-
01/2009 |
8 | 4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA
01/2020
-
11/2005 |
7 | Synthetic CathinoneIBA
03/2024
-
11/2014 |
7 | VaccinesIBA
02/2022
-
09/2014 |
7 | Naloxone (Narcan)FDA LinkGeneric
04/2020
-
07/2008 |
6 | Fentanyl (Sublimaze)FDA LinkGeneric
04/2024
-
04/2014 |
6 | Cocaine (Cocaine HCl)IBA
03/2024
-
10/2006 |
6 | Heroin (Diamorphine)IBA
12/2023
-
01/2017 |
6 | 5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2019
-
04/2005 |
6 | Interleukin-6 (Interleukin 6)IBA
01/2018
-
08/2007 |
5 | LigandsIBA
10/2021
-
03/2002 |
5 | R 121919IBA
01/2018
-
04/2009 |
5 | Corticotropin-Releasing HormoneIBA
01/2016
-
06/2002 |
4 | AcidsIBA
04/2024
-
10/2010 |
4 | Minocycline (Cyclops)FDA LinkGeneric
04/2022
-
10/2014 |
4 | Proteins (Proteins, Gene)FDA Link
01/2022
-
01/2016 |
4 | Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021
-
11/2007 |
4 | Methadone (Dolophine)FDA LinkGeneric
11/2020
-
01/2012 |
4 | Narcotic Antagonists (Opioid Antagonists)IBA
04/2020
-
07/2008 |
4 | volinanserinIBA
01/2019
-
05/2004 |
4 | antalarminIBA
01/2018
-
06/2002 |
4 | Nalbuphine (Nubain)FDA LinkGeneric
01/2018
-
11/2010 |
4 | Capsaicin (Zostrix)FDA Link
01/2018
-
09/2008 |
4 | CRF receptor type 1IBA
10/2017
-
12/2007 |
3 | AntibodiesIBA
12/2023
-
09/2014 |
3 | InflammasomesIBA
04/2022
-
01/2016 |
3 | HaptensIBA
02/2022
-
02/2016 |
3 | Interleukin-17 (Interleukin 17)IBA
01/2022
-
01/2021 |
3 | Dynorphins (Dynorphin)IBA
05/2021
-
03/2006 |
3 | Nitroglycerin (Dynamite)FDA LinkGeneric
01/2020
-
01/2017 |
3 | CytokinesIBA
11/2019
-
08/2007 |
3 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
01/2019
-
05/2004 |
3 | NeuropeptidesIBA
01/2018
-
11/2012 |
3 | lorcaserinIBA
01/2018
-
12/2015 |
3 | CorticosteroneIBA
01/2018
-
06/2002 |
3 | Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
10/2017
-
01/2004 |
3 | RimonabantIBA
10/2014
-
11/2013 |
3 | CannabinoidsIBA
09/2014
-
11/2013 |
3 | GABA-B ReceptorsIBA
03/2013
-
10/2010 |
3 | delta Opioid Receptors (delta Opioid Receptor)IBA
04/2012
-
11/2005 |
3 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2007
-
03/2002 |
2 | mu Opioid Receptors (mu Opioid Receptor)IBA
04/2024
-
01/2018 |
2 | Caffeine (No Doz)FDA LinkGeneric
03/2024
-
01/2024 |
2 | Ghrelin ReceptorsIBA
01/2023
-
11/2021 |
2 | N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
04/2022
-
01/2022 |
2 | NLR ProteinsIBA
01/2022
-
01/2016 |
2 | Myelin-Oligodendrocyte GlycoproteinIBA
01/2022
-
01/2021 |
2 | norbinaltorphimineIBA
05/2021
-
06/2010 |
2 | Sigma-1 ReceptorIBA
01/2021
-
01/2015 |
2 | 1- (2- (3,4- dichlorophenyl)ethyl)- 4- methylpiperazineIBA
01/2021
-
01/2015 |
2 | Messenger RNA (mRNA)IBA
01/2021
-
02/2006 |
2 | Toll-Like Receptor 2IBA
01/2021
-
05/2012 |
2 | Platelet Activating FactorIBA
04/2020
-
01/2020 |
2 | Amphetamine (Amfetamine)FDA LinkGeneric
01/2019
-
04/2005 |
2 | Oxycodone (Oxycontin)FDA LinkGeneric
01/2018
-
02/2016 |
2 | Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018
-
08/2013 |
2 | SaltsIBA
01/2018
-
04/2015 |